Form 4: BP4 S.r.l. Reduces Milestone Scientific Stake

BP4 S.r.l., a 10% owner and director of Milestone Scientific Inc. (MLSS), reported the sale of 50,158 shares of common stock through a pre-arranged Rule 10b5-1 trading plan.

Summary

• BP4 S.r.l., identified as a Director and 10% Owner of Milestone Scientific Inc. (MLSS), reported multiple sales of common stock.
• The transactions occurred on October 10, 2025, October 13, 2025, and October 14, 2025.
• A total of 50,158 shares of Common Stock, Par Value $0.001, were disposed of.
• The shares were sold at prices ranging from $0.5395 to $0.5501 per share.
• Following these transactions, BP4 S.r.l. beneficially owns 9,155,226 shares of Milestone Scientific Inc. common stock.
• The transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 4

Explanation: The sale of shares by a director and 10% owner is typically viewed negatively, as it can signal a lack of confidence. However, the use of a Rule 10b5-1 plan suggests the transactions were pre-scheduled and not a reaction to recent adverse developments, which slightly mitigates the negative sentiment.

Positives

• The sales were conducted under a Rule 10b5-1 trading plan, indicating they were pre-scheduled and not necessarily a reaction to recent negative company news.

Negatives

• A director and 10% owner reducing their stake can be perceived as a negative signal regarding future company prospects or valuation.
• The sales represent a reduction in the reporting person's beneficial ownership from 9,205,384 shares to 9,155,226 shares.

Risks

• Investor sentiment may be negatively impacted by the perception of a key insider reducing their holdings.
• Potential for increased selling pressure on the stock if other insiders follow suit or if the market interprets these sales as a lack of confidence.

Future Outlook

NA

Industry Context

This filing is specific to an insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• BP4 S.r.l., a director and 10% owner of Milestone Scientific Inc., engaged in sales of the company's common stock. These transactions are considered related party dealings due to BP4 S.r.l.'s significant ownership and board representation.

Stakeholder Impact

• Shareholders: May interpret the insider selling as a negative signal, potentially leading to decreased investor confidence and downward pressure on the stock price.
• Management/Employees: Could face questions regarding the company's outlook if key insiders are reducing their holdings.

Key Dates

Recommendation

While insider selling by a director and 10% owner is generally a negative signal, the transactions were executed under a Rule 10b5-1 plan, indicating they were pre-scheduled and not a reaction to new, undisclosed negative information. The total number of shares sold (50,158) represents a relatively small portion of BP4 S.r.l.'s total beneficial ownership (over 9 million shares). Therefore, a 'hold' recommendation is appropriate, advising investors to monitor future insider activity and company performance rather than reacting solely to these pre-planned sales.

Keywords

Milestone Scientific Inc., MLSS, BP4 S.r.l., Form 4, insider trading, stock sale, 10b5-1 plan, director, 10% owner, common stock